Patents by Inventor Gerard Zurawski

Gerard Zurawski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated mammalian monocyte cell genes; related reagents
    Publication number: 20030105303
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: November 8, 2002
    Publication date: June 5, 2003
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Gosse Jan Adema, Linde Meyaard, Daniel M. Gorman, Terrill K. McClanahan, Sandra M. Zurawski, Gerard Zurawski, Lewis L. Lanier, Joseph H. Phillips
  • Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor
    Patent number: 6479638
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using reagents relating to nucleic acids encoding monocyte cell proteins, and diagnostic kits, are also provided.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: November 12, 2002
    Assignee: Schering Corporation
    Inventors: Gosse Jan Adema, Linde Meyaard, Daniel M. Gorman, Terrill K. McClanahan, Sandra M. Zurawski, Gerard Zurawski, Lewis L. Lanier, Joseph H. Phillips, Jr.
  • Nucleic acids encoding mammalian proteinases; related reagents
    Patent number: 6140098
    Abstract: Nucleic acids encoding various proteases, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: August 30, 1996
    Date of Patent: October 31, 2000
    Assignee: Schering Corporation
    Inventors: Sriram Balasubramanian, John Ford, Daniel M. Gorman, Gerard Zurawski
  • Muteins of mammalian cytokine interleukin-13
    Patent number: 5696234
    Abstract: Methods for screening for partial agonists and for antagonists of mammalian cytokines. Particular positions of natural cytokines are identified as critical in providing these receptor mediated properties. Specific embodiments demonstrate properties of variations at these positions.
    Type: Grant
    Filed: August 1, 1994
    Date of Patent: December 9, 1997
    Assignee: Schering Corporation
    Inventors: Sandra M. Zurawski, Gerard Zurawski
  • Method of refolding human IL-13
    Patent number: 5596072
    Abstract: Nucleic acids encoding human IL-13, and purified IL-13 proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
    Type: Grant
    Filed: February 1, 1993
    Date of Patent: January 21, 1997
    Assignee: Schering Corporation
    Inventors: Janice Culpepper, Andrew McKenzie, Warren Dang, Gerard Zurawski
  • T cell activation markers
    Patent number: 5136022
    Abstract: A polypeptide designated H400 and its encoding nucleic acid are provided as markers specific for activated human T cells. Activated T cells are detected immunochemically by monoclonal antibodies specific for H400 or its immunogenic peptides. Activated T cells are also detected by nucleic acid probes directed to messenger RNA encoding the H400 protein.
    Type: Grant
    Filed: January 14, 1991
    Date of Patent: August 4, 1992
    Assignee: Schering Corporation
    Inventors: Keith D. Brown, Timothy R. Mosmann, Gerard Zurawski, Sandra M. Zurawski
  • Truncated human interleukin-a alpha
    Patent number: 5017692
    Abstract: Synthetic human interleukin-1.alpha. genes are provided whose codons are selected from those preferred by bacteria. High expression levels are obtained in an E. coli expression system for both native interleukin-1.alpha. and several mutant interleukin-1.alpha.'s.
    Type: Grant
    Filed: September 4, 1986
    Date of Patent: May 21, 1991
    Assignee: Schering Corporation
    Inventors: Gerard Zurawski, Sandra M. Zurawski
  • T cell activation markers
    Patent number: 5001230
    Abstract: A polypeptide designated H400 and its encoding nucleic acid are provided as markers specific for activated human T cells. Activated t cells are detected immunochemically by monoclonal antibodies specific for H400 or its immunogenic peptides. Activated T cells are also detected by nucleic acid probes directed to messenger RNA encoding the H400 protein.
    Type: Grant
    Filed: February 18, 1988
    Date of Patent: March 19, 1991
    Assignee: Schering Corporation
    Inventors: Keith D. Brown, Timothy K. Mosmann, Gerard Zurawski, Sandra M. Kurawski